603882 金域醫學
按盤價 
27.960 -0.240 (-0.851%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.916 | -2.465 | -4.860 | 7.571 | 36.885 |
| 總資產報酬率 ROA (%) | 2.029 | -1.733 | -3.441 | 5.015 | 22.357 |
| 投入資產回報率 ROIC (%) | 2.552 | -2.192 | -4.424 | 6.975 | 33.452 | 邊際利潤分析 |
| 銷售毛利率 (%) | 36.712 | 34.741 | 33.146 | 36.478 | 43.128 |
| 營業利潤率 (%) | 9.314 | -2.154 | -3.801 | 8.897 | 21.628 |
| 息稅前利潤/營業總收入 (%) | 8.988 | -3.074 | -6.140 | 8.657 | 21.376 |
| 淨利潤/營業總收入 (%) | 7.337 | -2.962 | -5.768 | 7.458 | 18.383 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 88.685 | -118.996 | -100.489 | 122.168 | 106.417 |
| 價值變動淨收益/利潤總額(%) | -2.688 | -0.944 | 15.475 | 35.522 | -0.325 |
| 營業外收支淨額/利潤總額(%) | -4.398 | 28.490 | 37.707 | -2.631 | -0.798 | 償債能力分析 |
| 流動比率 (X) | 3.132 | 3.238 | 3.278 | 3.073 | 2.327 |
| 速動比率 (X) | 3.038 | 3.147 | 3.189 | 2.981 | 2.239 |
| 資產負債率 (%) | 29.423 | 28.590 | 28.068 | 27.365 | 36.104 |
| 帶息債務/全部投入資本 (%) | 10.898 | 10.359 | 8.121 | 4.966 | 4.747 |
| 股東權益/帶息債務 (%) | 798.450 | 849.202 | 1,105.756 | 1,855.251 | 1,940.682 |
| 股東權益/負債合計 (%) | 234.831 | 245.063 | 251.139 | 259.693 | 172.122 |
| 利息保障倍數 (X) | 134.294 | 49.386 | 159.115 | -701.395 | -263.228 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 213.211 | 231.274 | 243.646 | 260.537 | 135.972 |
| 存貨周轉天數 (天) | 18.343 | 17.583 | 16.722 | 21.684 | 15.346 |
| 備註： | 即時報價更新時間為 27/08/2026 16:11 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
